making the case for LOreev XR
Brand: LOREEV XR, an extended-release, once-daily capsule version of lorazepam to treat Generalized Anxiety Disorder (GAD).
Background and Challenge: To convince healthcare providers of the value of switching patients from 3x/day lorazepam to a once-daily capsule.
Solution: Created data-driven sales material to support the value of switching appropriate patients to LOREEV XR.
Background and Challenge: To convince healthcare providers of the value of switching patients from 3x/day lorazepam to a once-daily capsule.
Solution: Created data-driven sales material to support the value of switching appropriate patients to LOREEV XR.
SAMPLE: Website loreevxrhcp.com presents information such as the smooth pharmacokinetic (PK) profile of LOREEV XR, which results in an even concentration of the drug over 24 hours, vs. lorazepam 3x/day. Another item highlighted is the metabolism of LOREEV XR, which is different than that of the majority of pharmaceuticals -- thus reducing the chances of drug-to-drug interactions.
SAMPLE: Created patient profiles for a healthcare provider audience. Reps used this tool to help doctors identify the kinds of patients that may be appropriate for LOREEV XR. Sample profile below:
